CoChat

Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study

Apostolopoulou, Konstantina, Künzel, Heike E., Gerum, Sabine, Merkle, Katrin, Schulz, Sebastian, Fischer, Evelyn, Pallauf, Anna, Brand, Volker, Bidlingmaier, Martin, Endres, Stephan, Beuschlein, Felix, Reincke, Martin · 2014 · The World Journal of Biological Psychiatry
Cited by 73

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The renin-angiotensin-aldosterone-system (RAAS) has gained increasing attention in the investigation of the pathogenesis of depression. Primary hyperaldosteronism (PA) is associated with a marked aldosterone excess. Prior studies on PA describe an increased prevalence of anxiety and sub-threshold depressive symptoms in these patients. METHODS: In a cross-sectional exploratory study we investigated 132 patients with PA. Twenty-seven patients were studied before initiation of specific treatment (U = untreated), 56 were studied 5.4 years after initiation of mineralocorticoid antagonist treatment (MRA) and 49 patients were studied 4.3 years after unilateral adrenalectomy (ADX). GAD-7 and PHQD self-rating questionnaires were used to assess symptoms for anxiety and depression. RESULTS: No significant difference was found between the three investigated groups. A higher prevalence for depression and anxiety compared to the normal population was found. Women of all groups had higher mean values compared to men, for depression in untreated patients this difference was found to be significant. Correlations between the psychopathology and hormones were only found for renin. Plasma renin concentration correlated significantly with anxious symptoms of untreated females. CONCLUSIONS: This study supports the RAAS to be involved in the pathogenesis of depression as patients with PA seem to be more depressive and anxious compared to the normal population. Gender differences in the regulation of the RAAS seem to be apparent, as females were more affected by the dysregulation than males.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/15622975.2012.665480

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Research works printed but not linked: 57

  1. Anstey KJ, 2009, Psychosom Med, 71, 937, 10.1097/PSY.0b013e3181beab60 · DOI
  2. Avery TL, 1984, N Z Med J, 97, 537
  3. Baghai TC, 2006, Mol Psychiatry, 11, 1003, 10.1038/sj.mp.4001884 · DOI
  4. Barden N, 1995, Trends Neurosci, 18, 6, 10.1016/0166-2236(95)93942-Q · DOI · Paper page
  5. 10.1016/j.psyneuen.2008.08.018 · DOI
  6. Bitran D, 1998, Pharmacol Biochem Behav, 60, 879, 10.1016/S0091-3057(98)00071-9 · DOI
  7. 10.1080/00221325.1988.10532148 · DOI
  8. Blanchard-Fields F, 1988, Psychol Aging, 3, 197, 10.1037/0882-7974.3.2.197 · doi:10.1037/0882-7974.3.2.197
  9. Born-Frontsberg E, 2009, J Clin Endocrinol Metab, 94, 1125, 10.1210/jc.2008-2116 · DOI · Paper page
  10. Briones-Aranda A, 2009, Pharmacol Biochem Behav, 92, 182, 10.1016/j.pbb.2008.11.008 · DOI
  11. 10.2165/00023210-200923070-00004 · DOI
  12. Chalmers DT, 1993, J Neurosci, 13, 914, 10.1523/JNEUROSCI.13-03-00914.1993 · DOI · Paper page
  13. Chen PS, 2006, Int Psychogeriatr, 18, 445, 10.1017/S1041610205002796 · DOI · Paper page
  14. 10.1310/tsr1501-13 · DOI · Paper page
  15. Daig I, 2009, Qual Life Res, 18, 669, 10.1007/s11136-009-9481-3 · DOI
  16. de Kloet ER, 2005, Nat Rev Neurosci, 6, 463, 10.1038/nrn1683 · DOI · Paper page
  17. de Kloet ER, 2008, Front Neuro endocrinol, 29, 268
  18. 10.1207/s15327752jpa4905_10 · DOI · Paper page
  19. Emanuele E, 2005, Arch Med Res, 36, 544, 10.1016/j.arcmed.2005.03.046 · DOI
  20. Fischer E, 2011, Rev Endocr Metab Disord, 12, 43, 10.1007/s11154-011-9163-7 · DOI
  21. Golden SH, 2007, Psychosom Med, 69, 529, 10.1097/PSY.0b013e3180f61c5c · DOI · Paper page
  22. 10.1080/00221320209598689 · DOI
  23. Hlavacova N, 2008, Horm Behav, 54, 90, 10.1016/j.yhbeh.2008.02.004 · DOI
  24. 10.1016/0306-4522(94)00407-V · DOI
  25. Holsboer F, 2000, Neuropsychopharmacology, 23, 477, 10.1016/S0893-133X(00)00159-7 · DOI · Paper page
  26. 10.1016/S0165-0327(00)00352-9 · DOI · Paper page
  27. Kellner M, 2008, Eur J Pharmacol, 583, 372, 10.1016/j.ejphar.2007.07.072 · DOI
  28. Khurshid KA, 2005, Am J Psychiatry, 162, 1226, 10.1176/appi.ajp.162.6.1226 · DOI
  29. Komukai K, 2010, Fundam Clin Pharmacol, 24, 687, 10.1111/j.1472-8206.2010.00854.x · DOI · Paper page
  30. Korte SM, 1995, Psychoneuroendocrinology, 20, 385, 10.1016/0306-4530(94)00069-7 · DOI · Paper page
  31. Kuroda Y, 1994, Brain Res, 648, 157, 10.1016/0006-8993(94)91916-X · DOI
  32. Lippi G, 2009, Semin Thromb Hemost, 35, 325, 10.1055/s-0029-1222611 · DOI · Paper page
  33. Lopez JF, 1998, Biol Psychiatry, 43, 547, 10.1016/S0006-3223(97)00484-8 · DOI · Paper page
  34. Lopez JF, 1999, Biol Psychiatry, 45, 934, 10.1016/S0006-3223(98)00224-8 · DOI
  35. Malinow KC, 1979, J Clin Psychiatry, 40, 358
  36. Meijer OC, 1994, Eur J Pharmacol, 266, 255, 10.1016/0922-4106(94)90134-1 · DOI · Paper page
  37. 10.1161/01.HYP.0000079505.25750.11 · DOI · Paper page
  38. Murck H, 2003, BMC Psychiatry, 3, 15, 10.1186/1471-244X-3-15 · DOI · Paper page
  39. Murck H, 2006, Pharmacopsychiatry, 39, 23, 10.1055/s-2006-931476 · DOI
  40. Panagiotakos DB, 2008, J Clin Nurs, 17, 688, 10.1111/j.1365-2702.2007.02056.x · DOI
  41. Reincke M, 2009, J Clin Endocrinol Metab, 94, 869, 10.1210/jc.2008-1851 · DOI · Paper page
  42. Reincke M, 2010, Horm Metab Res, 42, 435, 10.1055/s-0029-1246189 · DOI · Paper page
  43. Reul JM, 1993, Endocrinology, 133, 312, 10.1210/endo.133.1.8391426 · doi:10.1210/endo.133.1.8391426 · Paper page
  44. Rief W, 2004, J Affect Disord, 82, 271, 10.1016/j.jad.2003.11.006 · DOI · Paper page
  45. Ruiz MA, 2010, J Affect Disord.
  46. Schirpenbach C, 2009, Dtsch Arztebl Int, 106, 305
  47. Schussler P, 2010, Neuropsychobiology, 61, 113, 10.1159/000279301 · DOI
  48. Seckl JR, 1992, Neuroendocrinology, 55, 621, 10.1159/000126180 · DOI · Paper page
  49. Smythe JW, 1997, Pharmacol Biochem Behav, 56, 507, 10.1016/S0091-3057(96)00244-4 · DOI
  50. Sonino N, 2006, Psychother Psychosom, 75, 327, 10.1159/000093956 · DOI · Paper page
  51. Sonino N, 2011, J Clin Endocrinol Metab., 96, 383, 10.1210/jc.2010-2723 · DOI · Paper page
  52. Vonend O, 2010, Wien Klin Wochenschr, 122, 65, 10.1007/s00508-010-1313-5 · DOI
  53. Wang SS, 2008, Mol Psychiatry, 13, 786, 10.1038/mp.2008.38 · DOI · Paper page
  54. Watkins LL, 2006, Psychosom Med, 68, 651, 10.1097/01.psy.0000228342.53606.b3 · DOI · Paper page
  55. Yau JL, 1995, Neuroscience, 66, 571, 10.1016/0306-4522(94)00612-9 · DOI · Paper page
  56. Yau JL, 2002, Brain Res Mol Brain Res, 106, 117, 10.1016/S0169-328X(02)00418-7 · DOI
  57. Zhong P, 1995, Brain Res Mol Brain Res, 29, 23, 10.1016/0169-328X(94)00225-4 · DOI · Paper page

Cited by

See all 73

Metadata

Authors
Apostolopoulou, K., Künzel, H. E., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Pallauf, A., Brand, V., Bidlingmaier, M., Endres, S., Beuschlein, F., & Reincke, M.
Venue
The World Journal of Biological Psychiatry
Published
2012-05-08
Volume
15
Issue
1
Pages
26-35
ISSN
  • 1562-2975 (ISSN-L)
  • 1814-1412
OpenAlex
W2140262600
Cited by
73
References
14
FWCI
2.76
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study. https://app.cochat.ai/papers/10.3109/15622975.2012.665480
The paper
Apostolopoulou, K., Künzel, H. E., Gerum, S., Merkle, K., Schulz, S., Fischer, E., Pallauf, A., Brand, V., Bidlingmaier, M., Endres, S., Beuschlein, F., & Reincke, M. (2014). Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism: A cross-sectional study. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622975.2012.665480

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.